Advisory Committee; Technical Electronic Product Radiation Safety Standards Committee; Renewal, 4190 [2023-01219]
Download as PDF
<![CDATA[
4190
Federal Register / Vol. 88, No. 15 / Tuesday, January 24, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–N–0803]
Advisory Committee; Technical
Electronic Product Radiation Safety
Standards Committee; Renewal
AGENCY:
Food and Drug Administration,
HHS.
Notice; renewal of Federal
advisory committee.
ACTION:
The Food and Drug
Administration (FDA) is announcing the
renewal of the Technical Electronic
Product Radiation Safety Standards
Committee by the Commissioner of
Food and Drugs (the Commissioner).
The Commissioner has determined that
it is in the public interest to renew the
Technical Electronic Product Radiation
Safety Standards Committee for an
additional 2 years beyond the charter
expiration date. The new charter will be
in effect until December 24, 2024.
DATES: Authority for the Technical
Electronic Product Radiation Safety
Standards Committee will expire on
December 24, 2024, unless the
Commissioner formally determines that
renewal is in the public interest.
FOR FURTHER INFORMATION CONTACT:
Akinola Awojope, Center for Devices
and Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5216, Silver Spring,
MD 20993–0002, 301–636–0512,
Akinola.Awojope@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to 41 CFR 102–3.65 and approval by the
Department of Health and Human
Services and by the General Services
Administration, FDA is announcing the
renewal of the Technical Electronic
Product Radiation Safety Standards
Committee. The committee is a nondiscretionary Federal advisory
committee established to provide advice
and consultation to the Commissioner.
The Commissioner is charged with the
administration of the Radiation Control
for Health and Safety Act of 1968. This
Act creates the Technical Electronic
Product Radiation Safety Standards
Committee and requires the
Commissioner to consult with the
Committee before prescribing standards
for radiation emissions from electronic
products. This Committee provides
advice and consultation to the
Commissioner on the technical
feasibility, reasonableness, and
practicability of performance standards
for electronic products to control the
emission of radiation from such
tkelley on DSK125TN23PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:17 Jan 23, 2023
Jkt 259001
products, and may recommend
electronic product radiation safety
standards to the Commissioner for
consideration.
The Committee shall consist of 15
voting members including the Chair.
Members and the Chair are selected by
the Commissioner or designee from
among authorities knowledgeable in the
fields of science or engineering
applicable to electronic product
radiation safety. Members will be
invited to serve for overlapping terms of
up to 4 years. Terms of more than 2
years are contingent upon the renewal
of the Committee by appropriate action
prior to its expiration. Voting members
will include five members selected from
governmental agencies, including State
and Federal Governments, five members
from the affected industries, and five
members from the general public, of
which at least one shall be a
representative of organized labor. A
quorum shall consist of 10 members, of
which at least 3 shall be from the
general public, 3 from the government
agencies, and 3 from the affected
industries.
Further information regarding the
most recent charter and other
information can be found at https://
www.fda.gov/AdvisoryCommittees/
CommitteesMeetingMaterials/RadiationEmittingProducts/TechnicalElectronic
ProductRadiationSafety
StandardsCommittee/default.htm or by
contacting the Designated Federal
Officer (see FOR FURTHER INFORMATION
CONTACT). In light of the fact that no
change has been made to the committee
name or description of duties, no
amendment will be made to 21 CFR
14.100.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app.). For general information
related to FDA advisory committees,
please visit us at https://www.fda.gov/
AdvisoryCommittees/default.htm.
Dated: January 18, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–01219 Filed 1–23–23; 8:45 am]
BILLING CODE 4164–01–P
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
[OMB No. 0906–0047—Revision]
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request: Information
Collection Request Title: Ryan White
HIV/AIDS Program Parts A and B
Unobligated Balances and Rebate
Addendum Tables
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR should be
received no later than March 27, 2023.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 14N39, 5600 Fishers
Lane, Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Samantha Miller, the acting
HRSA Information Collection Clearance
Officer, at 301–594–4394.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the ICR title
for reference.
Information Collection Request Title:
Ryan White HIV/AIDS Program Parts A
and B Unobligated Balances and Rebate
Addendum Tables, OMB No. 0906–
0047—Revision.
Abstract: HRSA’s Ryan White HIV/
AIDS Program (RWHAP) funds and
coordinates with cities, states and
territories, and local clinics/communitybased organizations to deliver efficient
and effective HIV care, treatment, and
support to low-income people
diagnosed with HIV. Nearly two-thirds
of RWHAP clients (patients) live at or
below 100 percent of the federal poverty
level and approximately three-quarters
of RWHAP clients are racial and ethnic
SUMMARY:
E:\FR\FM\24JAN1.SGM
24JAN1
]]>Agencies
[Federal Register Volume 88, Number 15 (Tuesday, January 24, 2023)]
[Notices]
[Page 4190]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01219]
[[Page 4190]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2019-N-0803]
Advisory Committee; Technical Electronic Product Radiation Safety
Standards Committee; Renewal
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; renewal of Federal advisory committee.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
renewal of the Technical Electronic Product Radiation Safety Standards
Committee by the Commissioner of Food and Drugs (the Commissioner). The
Commissioner has determined that it is in the public interest to renew
the Technical Electronic Product Radiation Safety Standards Committee
for an additional 2 years beyond the charter expiration date. The new
charter will be in effect until December 24, 2024.
DATES: Authority for the Technical Electronic Product Radiation Safety
Standards Committee will expire on December 24, 2024, unless the
Commissioner formally determines that renewal is in the public
interest.
FOR FURTHER INFORMATION CONTACT: Akinola Awojope, Center for Devices
and Radiological Health, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 66, Rm. 5216, Silver Spring, MD 20993-0002, 301-
636-0512, [email protected].
SUPPLEMENTARY INFORMATION: Pursuant to 41 CFR 102-3.65 and approval by
the Department of Health and Human Services and by the General Services
Administration, FDA is announcing the renewal of the Technical
Electronic Product Radiation Safety Standards Committee. The committee
is a non-discretionary Federal advisory committee established to
provide advice and consultation to the Commissioner. The Commissioner
is charged with the administration of the Radiation Control for Health
and Safety Act of 1968. This Act creates the Technical Electronic
Product Radiation Safety Standards Committee and requires the
Commissioner to consult with the Committee before prescribing standards
for radiation emissions from electronic products. This Committee
provides advice and consultation to the Commissioner on the technical
feasibility, reasonableness, and practicability of performance
standards for electronic products to control the emission of radiation
from such products, and may recommend electronic product radiation
safety standards to the Commissioner for consideration.
The Committee shall consist of 15 voting members including the
Chair. Members and the Chair are selected by the Commissioner or
designee from among authorities knowledgeable in the fields of science
or engineering applicable to electronic product radiation safety.
Members will be invited to serve for overlapping terms of up to 4
years. Terms of more than 2 years are contingent upon the renewal of
the Committee by appropriate action prior to its expiration. Voting
members will include five members selected from governmental agencies,
including State and Federal Governments, five members from the affected
industries, and five members from the general public, of which at least
one shall be a representative of organized labor. A quorum shall
consist of 10 members, of which at least 3 shall be from the general
public, 3 from the government agencies, and 3 from the affected
industries.
Further information regarding the most recent charter and other
information can be found at https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Radiation-EmittingProducts/TechnicalElectronicProductRadiationSafetyStandardsCommittee/default.htm
or by contacting the Designated Federal Officer (see FOR FURTHER
INFORMATION CONTACT). In light of the fact that no change has been made
to the committee name or description of duties, no amendment will be
made to 21 CFR 14.100.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app.). For general information related to FDA advisory
committees, please visit us at https://www.fda.gov/AdvisoryCommittees/default.htm.
Dated: January 18, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-01219 Filed 1-23-23; 8:45 am]
BILLING CODE 4164-01-P
